Medicine & Health Journals Collection
医学与健康期刊合辑

2022年最新指标已更新

Taylor & Francis 旗下拥有2700+本国际优质期刊,包含全部主要学科领域,为研究人员与学者提供高质量的综合学术交流平台。旗下的医学与健康期刊组合拥有360+ 国际期刊, 超330+ 拥有影响因子,涵盖免疫学、肿瘤医学、药学、神经学、生物学、全科医学、医学教育学等多个领域,关注基础、转化和临床的各个阶段优质研究成果,拥有American Journal of Bioethics、Emerging Microbes & Infections、Clinical and Experimental Hypertension、Gut Microbes、Critical Reviews in Clinical Laboratory Sciences 等全球领先刊物。

Journals by Subjects

Emerging Microbes & Infections
Impact Factor: 13.2 (2022)
Q1
Emerging Microbes & Infections publishes research related to emerging infectious diseases, including epidemic surveillance, drug discovery and vaccine development.   
View journal
Expert Review of Vaccines
Impact Factor: 6.2 (2022)
Q2
A MEDLINE-indexed peer-reviewed journal providing expert commentary on the development, application, and clinical effectiveness of new vaccines. Topics include vaccine technology, vaccine adjuvants, prophylactic vaccines, and therapeutic vaccines. It offers accelerated publication.
View journal
OncoImmunology
Impact Factor: 7.2 (2022)
Q1
Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.
View journal
Human Vaccines & Immunotherapeutics
Impact Factor: 4.8 (2022)
Q1
Human Vaccines & Immunotherapeutics is an international journal of vaccinology and immunotherapy that publishes all aspects of work in these fields.
View journal

Cancer Biology & Therapy
Impact Factor: 3.6 (2022)
Q2
Publishes articles on the molecular basis of cancer, including translational diagnostic relevance or therapy, reviews, op-ed pieces and meeting reports.
View journal
Cancer Investigation
Impact Factor: 2.4 (2022)
Publishes original papers, essays, reports on new technologies, and reviews in the fields of translational and clinical oncology.It offers accelerated publication.
View journal

The European Journal of General Practice
Impact Factor: 3.4 (2022)
Q1
Publishes open access research on medical decision-making, healthcare delivery, medical education, and research methodology for primary care practice.
View journal
Annals of Medicine
Impact Factor: 4.4 (2022)
Q2

A peer-reviewed OA journal publishing across all areas of medicine as part of the Elevate Series

View journal

Expert Opinion on Therapeutic Patents
Impact Factor: 6.6 (2022)
Q1
Publishing reviews and patent evaluations covering recent patent claims/applications on compounds with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets, and patenting trends in a therapeutic area. This journal offers accelerated publication.
View journal
Pharmaceutical Biology
Impact Factor: 3.8 (2022)
Q1
Publishes open access research on natural medicines, biologically active natural products or their derivatives, and complex traditional medicine formulas.
View journal
Drug Delivery
Impact Factor: 6.0 (2022)
Q1
Publishes open access research on oral, pulmonary, nasal, parental and transdermal drug delivery systems and conjugates, and drug entry and targeting.
View journal
Pharmaceutical Development and Technology
Impact Factor: 3.4 (2022)
Q2
Publishes research on the design, development, manufacture, and evaluation of conventional and novel drug delivery systems. It offers accelerated publication.
View journal

Journal of Psychosomatic Obstetrics & Gynecology
Impact Factor: 3.1 (2022)
Q2
Focuses on psychosomatic and psychosocial aspects of women’s health in various disciplines such as gynecology, obstetrics, nursing, psychiatry and psychology.
View journal
Gynecological Endocrinology
Impact Factor: 2.0 (2022)
Publishes research on effects of endocrine glands and disorders, on reproduction in women and their implications in obstetrics and gynecology.
View journal

Renal Failure
Impact Factor: 3.0 (2022)
Q2
Publishes research articles on acute kidney injury, including pathology, nephrotoxicity, and transplantation- and diabetes-induced renal failure.
View journal

Computer Assisted Surgery
Impact Factor: 2.1 (2022)
Q2
Open-access, international journal for engineers and clinicians improving patient care with digital technologies in surgery, therapy and medical interventions.
View journal

Global Public Health
Impact Factor: 3.3 (2022)
Q2
Global Public Health publishes research into public health, health access and global health policies, development, inequalities and management.
View journal
Health, Risk & Society
Impact Factor: 2.1 (2022)
Health, Risk & Society publishes work on estimation and perception of risk to individuals and public healthcare and the policies and regulations affecting it.
View journal

了解更多医学与健康及其他各学科高水平国际期刊,请访问 Taylor & Francis Group 旗下学术期刊网站, 欢迎相关学科研究人员向您青睐的杂志投稿。

期刊网站:www.tandfonline.com

医学与健康领域部分期刊已开放加速出版服务!从投稿到发表最快仅需3周!

加速出版:https://taylorandfrancis.com/partnership/commercial/accelerated-publication/

Editing Services advert with pencil and envelopes background

Taylor & Francis 编辑润色服务

在准备向期刊提交稿件的时候,您需要协助吗? Taylor & Francis 编辑润色服务提供包括英语语言编辑、科学润色、翻译加编辑、稿件格式调整、相似度检查以及技术审核等,让您将时间集中在研究上。

Author Services Button

为期刊、图书作者提供的实用指南

在您准备撰写一篇国际学术论文时,一个为您提供必要指导和资源实用网站可以为您解答许多疑问!从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导,写作投稿前的必看网站!

Choose Open.

拥抱开放科学

开放获取对于作者、读者而言极具价值,开放科学让研究在更广泛的维度得到参考和使用,提升研究可见度和影响力,造福社会。您是否考虑发表开放获取文章?点击了解开放获取出版更多信息